What You Should Know:
Since 2018, we have been working with employer and payer partners to put Health Payment Accounts (HPAs) into the hands of Americans to help them more equitably access and afford healthcare.With Paytient available to nearly 1M members today, we wanted to better understand how the Paytient HPA changes behavior and attitudes toward the employers who sponsor it as an employee benefit.
Transforming Employee Well-being and Workplace Dynamics with Positive Impact
Read More
Hospital Deploys ZeroEyes AI Gun Detection Solution
What You Should Know:
ZeroEyes, the creators of the only AI-based gun detection video analytics platform that holds the US Department of Homeland Security SAFETY Act Designation, today announced that its proactive gun detection and intelligent situational awareness solution has been deployed at JPS Health Network in Fort Worth, Texas to mitigate gun-related violence. Located in Tarrant County, the 582-bed hospital includes an acute care facility, outpatient care centers, and
Read More
Boston Children’s Hospital Deploys Automated AI Tool for Hip Diagnosis
What You Should Know:
Hip disorders, comprising some of the world’s most common joint diseases, are especially prevalent among adolescents and young adults, causing stiffness, pain or a limp. But they can be hard to diagnose using solely 2D medical imaging.Helping to treat these disorders, the Boston Children’s Hospital’s (BCH’s) Adolescent and Young Adult Hip Preservation Program is the U.S.’s first to deploy a fully automated AI tool across its clinic.
Revolutionizing Hip
Read More
Molecular Glue Revolution: TenAces Biosciences Unveils AI-Powered Drug Discovery Platform
What You Should Know:
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced today the formation of TenAces Biosciences.TenAces is a startup developing a novel approach to discover new molecular glue therapies, leveraging machine learning to enhance development of treatments for a range of conditions.
Revolutionizing Molecular Glue Discovery with AI-Driven Targeted Protein
Read More
Personalis and ClearNote Join Forces for Early Cancer Detection
What You Should Know:
Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, today unveiled an alliance through which Personalis will expand its pharmaceutical service offerings by distributing ClearNote’s cutting-edge epigenomic 5-hydroxymethylcytosine (5hmC) platform.
Revolutionizing Cancer Detection and Treatment: ClearNote Health's Epigenomics Platform
ClearNote Health's Epigenomics Platform is a
Read More
Ohio State & CVS Form ACO to Elevate Medicare Care in Central Ohio
What You Should Know:
The Ohio State University Wexner Medical Center and CVS Accountable Care, part of CVS Health® (NYSE: CVS), today announced the creation of an accountable care organization (ACO) to improve the quality of care for Medicare beneficiaries by Ohio State providers in central Ohio.This coordinated approach to delivering care is centered around each patient’s unique needs and emphasizes preventive wellness and proactive treatment of chronic conditions.
CVS ACO and
Read More
Being Health Unveils $5.4M-Backed Modern Mental Health Practice in Lower Manhattan
What You Should Know:
Being Health, a psychiatrist-founded modern mental health practice, launches today to bring the best of psychiatry, psychotherapy, novel treatments (such as ketamine infusion therapy), functional medicine and wellness services (such as acupuncture and nutrition) all under one roof for a seamless patient experience in New York City.Being Health has raised $5.4 million to date in funding from 18 Park and HDS Capital.
Personalising Access to Mental Health
Read More
Culmination Bio and Merck Announce R&D Collaboration in Autoimmune Disease Research
What You Should Know:
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced an R&D collaboration with Merck, known as MSD, outside the United States and Canada, initially in the area of autoimmune disease.Under the terms of the master agreement, Merck will have access to both clinical (Electronic Health Records, labs, medications) and paired biospecimen (tissue and blood) data from several cohorts of various sizes and qualifications. This
Read More
Maven Clinic Partners with WellTheory to Offer Employees Autoimmune Care
What You Should Know:
WellTheory, a first-of-its-kind virtual solution for the 50 million Americans suffering with autoimmune disease, today announced its first employer partnership with Maven Clinic, the world's largest virtual clinic for women's and family health.Beginning today, Maven Clinic employees now have free access to WellTheory’s platform that offers evidence-based nutrition and lifestyle coaching to reduce autoimmune symptoms.
WellTheory's Holistic Program for Autoimmune
Read More
Coral Care Secures $1.3M to Expand Access to In-Home Pediatric Developmental Care
What You Should Know:
Coral Care, a digital health platform dedicated to enhancing access to pediatric developmental specialty care, has successfully secured $1.3 million in its latest funding round.With participation from Reach Capital, Greymatter Capital, Purpose Built Ventures, Hustle Fund, and various angel investors, the funding will support Coral Care's expansion efforts across Massachusetts, Rhode Island, New Hampshire, and additional markets in late 2024.
Bridging Gaps in
Read More
